Helus Pharma Inc. (HELP)

NASDAQ

$11.54

$+0.89

(+8.33%)

Regular Market

Helus Pharma Inc. (HELP) Live Price Chart

Last updated: ⁦2026-10-20 15:24:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Helus Pharma Inc. (HELP) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $11.54, with a market capitalization of $770.88M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.76 to $15.15. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$770.88M
Open	$10.75
Day's High	$15.15
Day's Low	$3.76
Previous Close	$10.69
Volume	468.51K
Average Volume	1.69M
P/E Ratio	--
52-Week High	$15.15
52-Week Low	$3.76
Dividend Yield	--
Earnings Date	--

Helus Pharma Inc. (HELP) Stock Price Today

Helus Pharma Inc. (HELP) is currently trading at $11.54 as of 2026-10-20 15:23:00, up 7.90% ($0.85) from the previous close of $10.69

During today's regular trading session, HELP has traded between $3.76 and $15.15, with a trading volume of 468.51K shares. The current price is near the middle of today's range.

Helus Pharma Inc. (HELP) 7-Day Stock Price Change

Over the past seven days, Helus Pharma Inc. (HELP) moved from $11.80 to $11.54, representing a decline of 2.25% ($0.27).

The stock traded between $9.97 and $12.73 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.72 million shares, up versus the previous seven-day period, indicating higher trading activity.

HELP 52-Week Price Position

Position in Range: 68.3%

52W Low$3.76

52W High$15.15

HELP is currently trading at $11.54, placing it 68.3% of the way from its 52-week low of $3.76 to its 52-week high of $15.15. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Helus Pharma Inc. (HELP)?

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Helus Pharma Inc. Information

Employees	50
Exchange	NASDAQ
Company Website	https://www.helus.com

How to Buy Helus Pharma Inc. (HELP) Stock on MEXC

Eligible investors can buy real shares of Helus Pharma Inc. (HELP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for HELP and Place Your Order

Open the RealStocks trading page and search for HELP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Helus Pharma Inc. (HELP) stock price today?

Helus Pharma Inc. (HELP) is currently trading at $ 11.54, up 7.90% ($0.85) from the previous close of $ 10.69. Intraday prices update in real time during regular trading hours.

2.Is HELP stock going up or down today?

As of 2026-10-20 15:23:00, HELP is trading at $ 11.54, up 7.90% ($0.85) from its previous close of $ 10.69. The stock has traded between $ 3.76 and $ 15.15 during today’s regular session. Past price movements do not guarantee future results.

3.What is HELP pre-market price?

As of 2026-10-20 15:23:00, HELP is trading at $ 10.81 in pre-market trading, up 1.08% ($0.12) from the previous close of $ 10.69. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is HELP after-hours price?

As of 2026-10-20 15:23:00, HELP is trading at $ 10.63 in after-hours trading, down 0.60% ($0.06) from the regular-session close of $ 10.69. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is HELP stock trading now?

HELP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does HELP sit relative to its 52-week high and low?

Over the past 52 weeks, HELP has traded between a low of $ 3.76 and a high of $ 15.15. At $ 11.54, the stock is positioned 68.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Helus Pharma Inc. in?

Helus Pharma Inc. (HELP) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Helus Pharma Inc.'s market capitalization and where is it listed?

Helus Pharma Inc. is listed on the NASDAQ exchange with a market capitalization of $ 770.88M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is HELP valued in terms of P/E ratio and EPS?

HELP trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Helus Pharma Inc. pay a dividend?

Helus Pharma Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.